TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -1 | 2 | -2 | 8 | 21 | 79 | 18 |
| S | %wins | 50 | 50 | 50 | 0 | 0 | 0 | 25 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/8/13 14:46 | 5/7/13 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Kelly William J | MA | O | Chief Ac | M.d | 96 | 4.82 | 4 | 20 | 0 | D | 131 | 90 | 84 | 38 | 34 | 10 | 4 | 5 | 1 | -4 | -12 | 7 | 21 | 84 | |
5/8/13 14:46 | 5/7/13 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Kelly William J | MA | O | Chief Ac | S.d | -183 | 9.14 | 4 | -20 | -100 | 0 | D | 131 | 90 | 84 | 38 | 34 | 10 | 4 | 5 | 1 | -4 | -12 | 7 | 21 | 84 |
9/4/12 20:41 | 8/31/12 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Kelly William J | MA | O | CFO | M.d | 419 | 4.65 | 1 | 90 | 0 | D | 60 | 69 | 22 | 40 | 42 | 21 | 10 | 3 | -2 | 7 | 9 | 9 | 20 | 73 | |
9/4/12 20:41 | 8/31/12 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Kelly William J | MA | O | CFO | S.d | -524 | 5.52 | 1 | -95 | -100 | 0 | D | 60 | 69 | 22 | 40 | 42 | 21 | 10 | 3 | -2 | 7 | 9 | 9 | 20 | 73 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |